Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema.

Korkmaz, Anil; Karti, Omer; Zengin, Mehmet O; Yuksel, Bora; Kusbeci, Tuncay

Korkmaz, Anil; Karti, Omer; Zengin, Mehmet O; Yuksel, Bora; Kusbeci, Tuncay.

Afiliación

Korkmaz A; Department of Ophthalmology, Bingöl State Hospital, Bingöl, Turkey.
Karti O; Department of Ophthalmology, Izmir Democracy University, Izmir, Turkey.
Zengin MO; Department of Ophthalmology, Izmir Katip Çelebi University, Izmir, Turkey.
Yuksel B; Department of Ophthalmology, University of Health Sciences Izmir Bozyaka Education and Research Hospital, Izmir, Turkey.
Kusbeci T; Department of Ophthalmology, University of Health Sciences Izmir Bozyaka Education and Research Hospital, Izmir, Turkey.

Saudi J Ophthalmol ; 36(3): 327-334, 2022.

Article en En | MEDLINE | ID: mdl-36276250

Palabras clave

Aflibercept; dexamethasone; diabetic macular edema; optical coherence tomography biomarkers; ranibizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Saudi J Ophthalmol Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google